| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-6147(97)01164-4 |
| P698 | PubMed publication ID | 9584621 |
| P50 | author | Taco J De Vries | Q38325787 |
| Louk Vanderschuren | Q59785733 | ||
| P2093 | author name string | A H Mulder | |
| A N Schoffelmeer | |||
| P2860 | cites work | Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 | Q28282369 |
| Cellular and molecular mechanisms of drug dependence | Q28283898 | ||
| Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization | Q28318966 | ||
| The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality | Q28326502 | ||
| The neural basis of drug craving: an incentive-sensitization theory of addiction | Q29547475 | ||
| Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex | Q34378202 | ||
| Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditioning model | Q34413503 | ||
| Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization | Q34420110 | ||
| The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward | Q34453945 | ||
| Localization of drug reward mechanisms by intracranial injections | Q35970774 | ||
| The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. | Q36724640 | ||
| Excitatory amino acids and drugs of abuse: a role for N-methyl-d-aspartate receptors in drug tolerance, sensitization and physical dependence | Q40480630 | ||
| Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists | Q41851245 | ||
| Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist | Q42555210 | ||
| Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation | Q44336542 | ||
| Amphetamine behavioral sensitization and the excitatory amino acids | Q44745120 | ||
| Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration? | Q46204457 | ||
| MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. | Q48163465 | ||
| Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. | Q48230956 | ||
| Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine | Q48638665 | ||
| Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward | Q48846432 | ||
| Systemic pretreatment with MK-801 (dizocilpine) increases breaking points for self-administration of cocaine on a progressive-ratio schedule in rats. | Q51558396 | ||
| The NMDA receptor and cocaine: Evidence that MK-801 can induce behavioral sensitization effects | Q51597277 | ||
| Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference | Q51608371 | ||
| R-(+)-HA-966, an antagonist for the glycine/NMDA receptor, prevents locomotor sensitization to repeated cocaine exposures. | Q51610617 | ||
| Cocaine behavioral sensitization and the excitatory amino acids. | Q51631322 | ||
| Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. | Q51759796 | ||
| Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801 | Q52052445 | ||
| Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice. | Q52192496 | ||
| Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol. | Q52199365 | ||
| The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats. | Q52217463 | ||
| The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. | Q52228000 | ||
| Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. | Q52228738 | ||
| Respiratory effects of the N-methyl-D-aspartate (NMDA) antagonist, MK-801, in intact and vagotomized chronic cats | Q70249495 | ||
| Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment | Q71696058 | ||
| MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation | Q71930932 | ||
| Neurotransmitter regulation of dopamine neurons in the ventral tegmental area | Q72215317 | ||
| MK-801 prevents the development of behavioral sensitization during repeated morphine administration | Q72482348 | ||
| The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801 | Q72777581 | ||
| Does dizocilpine (MK-801) inhibit the development of morphine-induced behavioural sensitization in rats? | Q73994266 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 79-81 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Trends in Pharmacological Sciences | Q2451474 |
| P1476 | title | Dizocilpine (MK801): use or abuse? | |
| P478 | volume | 19 |
| Q34770616 | Behavioral performance altering effects of MK-801 in zebrafish (Danio rerio). |
| Q33716890 | Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity |
| Q34714448 | Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine |
| Q95442616 | Does the noncompetitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration? |
| Q34126167 | The pharmacological basis of contemporary pain management |
| Q95301997 | Tzschentke and schmidt reply |
Search more.